SK
SKBBY
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.—
Price
Daily candles with volume.
No data for this timeframe.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 Clinical trial readout
🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 26, 2026
Trial readout
🔒 Fresh data, subscribers only
Oct 18, 2026
Trial readout
T-90d Trial Readout: KL590586 Capsule (Phase 2)
Trial: A Study of KL590586 in Patients With Advanced Solid Tumors Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Phase: Phase 2 |…
Oct 12, 2026
Trial readout
Results Pending: SKB264 (Phase 2) — Completed 73d ago
Trial: SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Phase…
Oct 12, 2026
Trial readout
T-90d Trial Readout: KL590586 Capsule (Phase 2)
Trial: A Study of KL590586 in Patients With Advanced Solid Tumors Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Phase: Phase 2 |…
Oct 12, 2026
Trial readout
T-90d Trial Readout: SKB264 (Phase 2)
Trial: SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Phase: Phase 2…